Z-0951-2022 Class II Ongoing

Recalled by Qiagen Sciences LLC — Germantown, MD

FDA device recall Z-0951-2022 was initiated by Qiagen Sciences LLC on Feb 25, 2022 and is designated Class II. Reason for recall: False positive or false negative G12C (12CYS) mutation result for the KRAS Mutation Status resulting from Flags/Warnings may invalidate the result for one or more individual mutation target of the… The recall status is ongoing. Affected quantity: 435 kits.

Recall details

Product Type
Devices
Report Date
Apr 27, 2022
Initiation Date
Feb 25, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
435 kits

Product description

therascreen KRAS RGQ PCR Kit (24) Model Number(s): REF 870021 (US IVD)

Reason for recall

False positive or false negative G12C (12CYS) mutation result for the KRAS Mutation Status resulting from Flags/Warnings may invalidate the result for one or more individual mutation target of the kit.

Distribution pattern

AZ CA CT FL GA IL IN MA MN NC NY OK OR PA TN TX WV

Code information

All lot numbers. GTIN number: 04053228002048

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0951-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0951-2022. Report a data issue: hello@regdatalab.com.